We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
0.03%
This Fund
S&P 500
This Quarter
Est. Return
-3.31%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.38B
AUM Growth
+$407M
(+21%)
Cap. Flow
+$540M
Cap. Flow
% of AUM
22.68%
Top 10 Holdings %
Top 10 Hldgs %
32.09%
Holding
169
New
35
Increased
72
Reduced
38
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$245M |
| 2 |
Apple
AAPL
|
+$91.7M |
| 3 |
PENN Entertainment
PENN
|
+$47.4M |
| 4 |
Eversource Energy
ES
|
+$42.9M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coursera
COUR
|
+$25.2M |
| 2 |
Applovin
APP
|
+$22.4M |
| 3 |
Cognizant
CTSH
|
+$20.7M |
| 4 |
Corpay
CPAY
|
+$19.5M |
| 5 |
Akamai
AKAM
|
+$18.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.13% |
| 2 | Communication Services | 13.73% |
| 3 | Healthcare | 12.21% |
| 4 | Consumer Discretionary | 11.73% |
| 5 | Energy | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
Coursera
COUR
$1.52B
| – | – |
-1,934,393
| Closed | -$25.2M |
|
152
Capri Holdings
CPRI
$1.75B
| – | – |
-58,146
| Closed | -$2.09M |
|
|
153
Cognizant
CTSH
$26.3B
| – | – |
-317,554
| Closed | -$20.7M |
|
|
FISV
154
Fiserv Inc
FISV
$27.8B
| – | – |
-65,504
| Closed | -$8.26M |
|
155
Flex
FLEX
$44.2B
| – | – |
-376,331
| Closed | -$7.84M |
|
156
Genesco
GCO
$419M
| – | – |
-57,100
| Closed | -$1.43M |
|
157
Hasbro
HAS
$13.3B
| – | – |
-163,584
| Closed | -$10.6M |
|
158
Huntington Ingalls Industries
HII
$13B
| – | – |
-74,021
| Closed | -$16.8M |
|
159
Insteel Industries
IIIN
$626M
| – | – |
-183,189
| Closed | -$5.7M |
|
160
Match Group
MTCH
$8.43B
| – | – |
-252,245
| Closed | -$10.6M |
|
161
QuidelOrtho
QDEL
$938M
| – | – |
-38,218
| Closed | -$3.17M |
|
162
Raymond James Financial
RJF
$34.5B
| – | – |
-49,016
| Closed | -$5.09M |
|
|
163
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| – | – |
-400,000
| Closed | -$177M |
|
164
STRATTEC Security
STRT
$349M
| – | – |
-16,589
| Closed | -$301K |
|
165
CALL
AT&T
T
$165B
| – | – |
-286,700
| Closed | -$4.57M |
|
166
Whirlpool
WHR
$2.75B
| – | – |
-22,941
| Closed | -$3.41M |
|
167
Zumiez
ZUMZ
$330M
| – | – |
-181,108
| Closed | -$3.02M |
|
|
EQC
168
DELISTED
Equity Commonwealth
EQC
| – | – |
-306,551
| Closed | -$6.21M |
|
|
ROVR
169
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| – | – |
-1,321,728
| Closed | -$6.49M |
|
Similar funds
SIG
ORCP
ET
GC
MIAS
TAL
IIP
WCMNY
Invenomic Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Invenomic Capital Management held 169 positions worth $2.38B, up 21% from $1.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Invenomic Capital Management deployed $540M of net new capital in Q3 2023, opening 35 new positions and adding to 72 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 550,000 shares worth $235M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 27% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Applovin, an estimated $22.4M trimmed.
- Invenomic Capital Management's largest Q3 2023 buy was State Street SPDR S&P 500 ETF Trust: 550,000 shares worth $235M.
- Invenomic Capital Management added most to Citigroup in Q3 2023, an estimated $37.9M increase.
- Invenomic Capital Management's biggest Q3 2023 reduction was Applovin, cutting an estimated $22.4M.
- Invenomic Capital Management fully exited Coursera in Q3 2023, selling an estimated $25.2M.
- Invenomic Capital Management's ten largest holdings make up 32% of its $2.38B portfolio in Q3 2023.
- Invenomic Capital Management opened 35 new positions and closed 24 in Q3 2023.
- Invenomic Capital Management's portfolio value rose 21% quarter-over-quarter to $2.38B.
Based on Invenomic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.